Meningitis C vaccination Information Chase Lodge Hospital North West London NW7 2ED


Public Health England is currently urging all University freshers to have a booster to protect them against Meningitis C before they go to University.

In the UK all children are offered Meningitis C vaccine to protect them against Meningitis C infection but, as the protection offered by the vaccine can wane, a booster for university freshers is now available.

Dr Shamez Ladhani, an expert on meningococcal disease for Public Health England said: “The addition of the ‘Freshers’ MenC immunisation will contribute to the highly successful vaccination programme we have in the UK.

“The MenC booster is available to any student entering university for the first time born after September 1995 and who received the MenC vaccine under the age of ten years, or any student of any age entering or being at university who is unvaccinated against MenC disease. Anyone born before September 1995 and who received the MenC vaccination at secondary school won’t need another dose.

“If you can’t remember, the best thing to do is to check with your doctor before you go off to university. Ideally, Freshers should have the MenC vaccination at least two weeks before they go away to study. However, anyone starting university without the booster should arrange to get it as soon as possible, via their university or college health centre or GP. If in doubt, there is no harm in having an extra dose.”

The Meningitis C vaccine is available here at Chase Lodge. Please ask at Reception for details.

We offer a full range of immunizations here at Chase Lodge including some which are not currently available on the NHS, in particular Meningitis B, Chickenpox (varicella), and BCG.

Meningitis and Septicaemia

  • There are approximately 1500 reported cases of meningococcal disease each year in the UK. This is the most common cause of bacterial meningitis
  • Most people will make a good recovery, but meningococcal disease can cause very severe illness that can rapidly result in death and leave people with severe after-effects.
  • Around 7% of cases of meningococcal disease will result in death. Of those who survive, 15% can be left with severe and disabling after-effects such as loss of hearing and sight, brain damage and, where septicaemia has occurred, damage to major organs, loss or digits and limbs.
  • Septicaemia is generally more life-threatening than meningitis.
  • Meningococcal disease can strike at any age, but most cases occur in babies and young children, the next most vulnerable group is teenagers and young adults.

For further information on Meningitis, visit the following websites:

Download this information as a leaflet